Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Profiling Mrna and Mirna Expression Variations Associated With Cyclin-Dependent Kinase Pathway in the Low-Grade Luminal Early Breast Cancer Publisher Pubmed



Am Khamaneh Amir MAHDI ; N Mohajeri NASRIN ; B Naghili BEHROOZ ; N Zarghami NOSRATOLLAH
Authors

Source: Journal of Applied Genetics Published:2025


Abstract

Luminal A and B subtypes of breast tumors have fluctuated in proliferation rates, which arise from cell cycle dysregulation in cancer. Besides, microRNAs can regulate various cell processes through integration with mRNA. miRNAs that target the cell cycle are significant because of their prediction capability of prognosis. The objective of this study is to discover the integration between miRNA-mRNA and miRNA-miRNA related to cyclin-dependent kinase. Thirty-four pairs of human primary breast cancer and tumor margin samples from luminal breast cancer patients were investigated to assess the expression levels of CCND1, E2F1, miR-124, miR-503, miR-449a, and miR-449b. Afterward, the expression levels of mRNAs and miRNAs were investigated by real-time PCR. Statistical analysis was conducted to compare the expression levels between breast cancer and corresponding normal tissues. The protein expressions of E2F1 and CCND1 were verified by western blotting. Further, the correlation between mRNAs and miRNAs was calculated. E2F1 was significantly increased in both luminal A and B patients, while CCND1 was upregulated only in luminal B. Significant differences in all miRNAs were detected in both luminal A and B biopsy specimens (p < 0.0001). The correlation analysis revealed a positive strong correlation between miR-124 and E2F1 in luminal A patient. Moreover, the correlation test confirmed the ability of miR-449a to increase the CCND1 gene in luminal B subtypes. Also, miRNA correlation exhibited the miRNA-miRNA interaction in luminal breast cancer. This study demonstrated the novel miRNA-mRNA and miRNA-miRNA interactions, providing new insights into the molecular integration in luminal A and B patients. The authors propose that this research could contribute to introducing valuable biomarkers for luminal cancerous cells. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. An Innovative Systematic Approach Introduced the Involved Lncrna-Mir-Mrna Network in Cell Cycle and Proliferation After Conventional Treatments in Breast Cancer Patients, Cell Cycle (2022)
2. Plasma Mir-21, Mir-155, Mir-10B, and Let-7A As the Potential Biomarkers for the Monitoring of Breast Cancer Patients, Scientific Reports (2018)
3. Expression Profiles and Functional Prediction of Long Non-Coding Rnas Linc01133, Zeb1-As1 and Abhd11-As1 in the Luminal Subtype of Breast Cancer, Journal of Translational Medicine (2021)
Experts (# of related papers)
View all Related Experts
Alimohammad Alizadeh (3)
Lobat Geranpayeh (2)
Other Related Docs
4. Expression of the Three Components of Linear Ubiquitin Assembly Complex in Breast Cancer, PLoS ONE (2018)
5. Microrna As a Systemic Intervention in the Specific Breast Cancer Subtypes With C-Myc Impacts; Introducing Subtype-Based Appraisal Tool, Journal of Cellular Physiology (2018)
6. Expression of the Circulating and the Tissue Micrornas After Surgery, Chemotherapy, and Radiotherapy in Mice Mammary Tumor, Tumor Biology (2016)
7. The Upregulation of Hsa-Mir-181B-1 and Downregulation of Its Target Cyld in the Late-Stage of Tumor Progression of Breast Cancer, Indian Journal of Clinical Biochemistry (2020)
8. The Role of Oncomirs in the Pathogenesis and Treatment of Breast Cancer, Biomedicine and Pharmacotherapy (2016)
9. Mir-483-3P Suppresses the Proliferation and Progression of Human Triple Negative Breast Cancer Cells by Targeting the Hdac8>Oncogene, Journal of Cellular Physiology (2020)
10. Up-Regulation of Foxn3-As1 in Invasive Ductal Carcinoma of Breast Cancer Patients, Heliyon (2021)
11. Expression of Mirnas Targeting Mtor and S6k1 Genes of Mtor Signaling Pathway Including Mir-96, Mir-557, and Mir-3182 in Triple-Negative Breast Cancer, Applied Biochemistry and Biotechnology (2018)
12. An Insight Into the Potential Role of Linc00968 in Luminal Breast Cancer: Case-Control Study and Bioinformatics Analysis, Biochemistry and Biophysics Reports (2023)
13. Constructing Mrna, Mirna, Circrna and Lncrna Regulatory Network by Analysis of Microarray Data in Breast Cancer, Gene Reports (2022)
14. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
15. The Expression Levels of Circulating Mir-129 and Mir-203A in Association With Breast Cancer and Related Metastasis, Iranian Journal of Public Health (2022)
16. Integrative Analyses of Triple Negative Dysregulated Transcripts Compared With Non-Triple Negative Tumors and Their Functional and Molecular Interactions, Journal of Cellular Physiology (2019)
17. Differential Mirnas Expression Pattern of Irradiated Breast Cancer Cell Lines Is Correlated With Radiation Sensitivity, Scientific Reports (2020)
18. Aberrant Expression of Breast Development-Related Micrornas, Mir-22, Mir-132, and Mir-212, in Breast Tumor Tissues, Journal of Breast Cancer (2016)
19. A Novel Panel of Blood-Based Micrornas Capable of Discrimination Between Benign Breast Disease and Breast Cancer at Early Stages, RNA Biology (2021)
20. Ectopic Expression of Mir-34A/-328 Sensitizes Breast Cancer Stem Cells to Gamma Rays/Doxorubicin by Bcl2/Abcg2 Targeting, Molecular Biology Reports (2025)